(Q84330048)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20512522%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

meta-analysis

0 references

title

Safety and benefits of protamine administration to revert anticoagulation soon after coronary angioplasty. A meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20512522%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference

1 reference

Giuseppe De Luca

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20512522%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Guido Parodi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20512522%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

David Antoniucci

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20512522%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

publication date

1 November 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20512522%20AND%20SRC:MED&resulttype=core&format=json

Journal of Thrombosis and Thrombolysis

4 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20512522%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20512522%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20512522%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

page(s)

452-458

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20512522%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11239-010-0482-4

4 February 2020

exact match

0 references

cites work

Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial

1 reference

12 December 2020

Immediate protamine administration and sheath removal following percutaneous coronary intervention: a prospective study of 429 patients

1 reference

12 December 2020

Protamine: a review of its toxicity

1 reference

12 December 2020

In-laboratory removal of femoral sheath following protamine administration in patients having intracoronary stent implantation

1 reference

12 December 2020

Protamine induces endothelium-dependent vasodilatation of the pulmonary artery

1 reference

12 December 2020

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

1 reference

12 December 2020

Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale

1 reference

12 December 2020

Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial

1 reference

12 December 2020

Impact of heparin neutralization by protamine on restenosis after coronary stent implantation

1 reference

12 December 2020

Safety of heparin reversal with protamin and immediate sheath removal after coronary angioplasty

1 reference

12 December 2020

Administration of protamine after coronary stent deployment

1 reference

12 December 2020

Immediate removal of femoral-sheath following protamine administration in patients undergoing intracoronary paclitaxel-eluting-stent implantation

1 reference

12 December 2020

Comparison of bivalirudin and unfractionated heparin plus protamine in patients with coronary heart disease undergoing percutaneous coronary intervention (from the Antithrombotic Regimens aNd Outcome [ARNO] trial).

1 reference

12 December 2020

Safety of immediate reversal of anticoagulation by protamine to reduce bleeding complications after infarct artery stenting for acute myocardial infarction and adjunctive abciximab therapy

1 reference

12 December 2020

Complement activation from protamine sulfate administration after coronary angiography

1 reference

12 December 2020

In-laboratory femoral sheath removal after heparin reversal by protamine after percutaneous coronary intervention

1 reference

12 December 2020

Partial reversal of heparin anticoagulation by intravenous protamine in abciximab-treated patients undergoing percutaneous intervention

1 reference

12 December 2020

Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; Systematic overview and meta-analysis of randomized trials.

1 reference

12 December 2020

Protamine--antagonist to heparin

1 reference

12 December 2020

Prasugrel versus clopidogrel in patients with acute coronary syndromes

1 reference

12 December 2020

Efficacy and safety of drug-eluting stents in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials

1 reference

12 December 2020

10.1007/S11239-010-0482-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20512522%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference